Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2025 Aug 12;16:1670563. doi: 10.3389/fimmu.2025.1670563

Correction: Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer

Peng Jin 1, Xiaoyan Ji 2, Jingchao Bai 3, Wei Su 4, Bin Ke 1, Yong Liu 1, Bin Wang 5,*
PMCID: PMC12378907  PMID: 40873578

In the published article, there was an error in the Funding statement. The funder “Tianjin Key Medical Discipline (Specialty) Construction Project, TJYXZDXK-009A” was erroneously omitted. The correct Funding statement appears below.

“The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grants from the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A), Introduction of Talents and Doctoral Startup Fund (B2301 and B2320), The China Postdoctoral Science Foundation (2023M742618) and China National Postdoctoral Program for Innovative Talent (BX20240254).”

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES